Amyris, Inc.

The firm is debtors’ counsel to this leading synthetic biology company, based in Emeryville California, in connection with its chapter 11 bankruptcy case pending in Delaware bankruptcy court. Amyris was founded in 2003 to create a more stable supply of a key antimalarial treatment. Through its cutting-edge science, artemisinin—the most effective anti-malarial drug in the world—is now consistently available to treat the deadly disease. Using the same technological innovations that produced artemisinin, Amyris has become the world’s leading manufacturer of ingredients made with synthetic biology. Amyris provides sustainable ingredients that are eco-friendly alternatives to raw materials sourced for flavors and fragrances, sweeteners, cosmetics, pharmaceuticals, and other consumer products.

Our website uses cookies to enhance site navigation, analyze site usage, and assist in our marketing efforts. By continuing to browse this website, you agree to our Privacy Policy.